Pyridostigmine restores cardiac autonomic balance after small myocardial infarction in mice

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Durand, Marina T ^a   Becari, Christiane ^a   De Oliveira, Mauro ^a   Do Carmo, Jussara M ^b   Silva, Carlos Alberto Aguiar ^a   Prado, Cibele M ^a   Fazan Jr , Rubens ^a   Salgado, Helio C ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; ISOFLURANE; PROPRANOLOL; PYRIDOSTIGMINE; CARDIOTONIC AGENT; CHOLINESTERASE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTERIAL PRESSURE; ARTICLE; CAROTID ARTERY; CHOLINERGIC TRANSMISSION; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DIASTOLE; HEART EJECTION FRACTION; HEART HEMODYNAMICS; HEART INDEX; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HEART RATE; HEART WEIGHT; LEFT CORONARY ARTERY; MALE; MOUSE; NONHUMAN; PARASYMPATHETIC TONE; SYMPATHETIC TONE; SYSTOLE; TACHYCARDIA; TELEMETRY; VAGUS NERVE STIMULATION; VAGUS TONE; ANIMAL; BLOOD PRESSURE; C57BL MOUSE; DRUG EFFECTS; DRUG SCREENING; HEART MUSCLE; MYOCARDIAL INFARCTION; PATHOLOGY; PATHOPHYSIOLOGY; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; BLOOD PRESSURE; CARDIOTONIC AGENTS; CHOLINESTERASE INHIBITORS; DRUG EVALUATION, PRECLINICAL; INFUSIONS, SUBCUTANEOUS; MALE; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; MYOCARDIUM; PYRIDOSTIGMINE BROMIDE; VENTRICULAR FUNCTION, LEFT;

EID: 84913578109     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0104476     Document Type: Article

References (57)

1. Ahn D, Cheng L, Moon C, Spurgeon H, Lakatta EG, et al. (2004) Induction of myocardial infarcts of a predictable size and location by branch pattern probability-assisted coronary ligation in C57BL/6 mice. Am J Physiol Heart Circ Physiol 286: H1201-1207. doi:10.1152/ajpheart.00862.2003 (Pubitemid 38248638)
2. Salto-Tellez M, Yung Lim S, El-Oakley RM, Tang TPL, ALmsherqi ZAM, et al. (2004) Myocardial infarction in the C57BL/6J mouse: a quantifiable and highly reproducible experimental model. Cardiovasc Pathol Off J Soc Cardiovasc Pathol 13: 91-97. doi:10.1016/S1054-8807(03)00129-7 (Pubitemid 38366427)
3. Yutzey KE, Robbins J (2007) Principles of genetic murine models for cardiac disease. Circulation 115: 792-799. doi:10.1161/CIRCULATIONAHA.106. 682534. (Pubitemid 46294746)
4. Carlson SH, Wyss JM (2000) Long-term telemetric recording of arterial pressure and heart rate in mice fed basal and high NaCl diets. Hypertension 35: E1-5.
5. Butz GM, Davisson RL (2001) Long-term telemetric measurement of cardiovascular parameters in awake mice: a physiological genomics tool. Physiol Genomics 5: 89-97. (Pubitemid 33675206)
6. Binkley PF, Nunziata E, Haas GJ, Nelson SD, Cody RJ (1991) Parasympathetic withdrawal is an integral component of autonomic imbalance in congestive heart failure: demonstration in human subjects and verification in a paced canine model of ventricular failure. J Am Coll Cardiol 18: 464-472.
7. Ishise H, Asanoi H, Ishizaka S, Joho S, Kameyama T, et al. (1998) Time course of sympathovagal imbalance and left ventricular dysfunction in conscious dogs with heart failure. J Appl Physiol Bethesda Md 1985 84: 1234-1241. (Pubitemid 28158688)
8. Bibevski S, Dunlap ME (2011) Evidence for impaired vagus nerve activity in heart failure. Heart Fail Rev 16: 129-135. doi:10.1007/s10741-010-9190-6.
9. Olshansky B, Sabbah HN, Hauptman PJ, Colucci WS (2008) Parasympathetic nervous system and heart failure: pathophysiology and potential implications for therapy. Circulation 118: 863-871. doi:10.1161/CIRCULATIONAHA.107.760405.
10. LaCroix C, Freeling J, Giles A, Wess J, Li Y-F (2008) Deficiency of M2 muscarinic acetylcholine receptors increases susceptibility of ventricular function to chronic adrenergic stress. Am J Physiol Heart Circ Physiol 294: H810-820. doi:10.1152/ajpheart.00724.2007. (Pubitemid 351253292)
11. Lara A, Damasceno DD, Pires R, Gros R, Gomes ER, et al. (2010) Dysautonomia due to reduced cholinergic neurotransmission causes cardiac remodeling and heart failure. Mol Cell Biol 30: 1746-1756. doi:10.1128/MCB. 00996-09
12. Katare RG, Ando M, Kakinuma Y, Arikawa M, Yamasaki F, et al. (2010) Differential regulation of TNF receptors by vagal nerve stimulation protects heart against acute ischemic injury. J Mol Cell Cardiol 49: 234-244. doi:10.1016/j.yjmcc.2010.03.007
13. De Ferrari GM, Schwartz PJ (2011) Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions. Heart Fail Rev 16: 195-203. doi:10.1007/s10741-010-9216-0
14. Li M, Zheng C, Sato T, Kawada T, Sugimachi M, et al. (2004) Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats. Circulation 109: 120-124. doi:10.1161/01.CIR.0000105721.71640.DA. (Pubitemid 38056032)
15. Zheng C, Li M, Inagaki M, Kawada T, Sunagawa K, et al. (2005) Vagal stimulation markedly suppresses arrhythmias in conscious rats with chronic heart failure after myocardial infarction. Conf Proc Annu Int Conf IEEE Eng Med Biol Soc IEEE Eng Med Biol Soc Conf 7: 7072-7075. doi:10.1109/IEMBS.2005.1616135
16. Hauptman PJ, Schwartz PJ, Gold MR, Borggrefe M, Van Veldhuisen DJ, et al. (2012) Rationale and study design of the increase of vagal tone in heart failure study: INOVATE-HF. Am Heart J 163: 954-962.e1. doi:10.1016/j.ahj.2012. 03.021
17. Schwartz PJ (2013) Vagal stimulation for heart diseases: from animals to men. An example of translational cardiology. Neth Heart J Mon J Neth Soc Cardiol Neth Heart Found 21: 82-84. doi:10.1007/s12471-012-0368-5
18. Desai MY, Watanabe MA, Laddu AA, Hauptman PJ (2011) Pharmacologic modulation of parasympathetic activity in heart failure. Heart Fail Rev 16: 179-193. doi:10.1007/s10741-010-9195-1
19. Nobrega ACL, Loures DL, Pontes PV, Sant'anna ID, Mesquita ET (2008) Cholinergic stimulation with pyridostigmine prevents the impairment in ventricular function during mental stress in coronary artery disease patients. Int J Cardiol 125: 418-421. doi:10.1016/j.ijcard.2007.01.043 (Pubitemid 351419248)
20. Lataro RM, Silva CAA, Fazan R Jr, Rossi MA, Prado CM, et al. (2013) Increase in parasympathetic tone by pyridostigmine prevents ventricular dysfunction during the onset of heart failure. Am J Physiol Regul Integr Comp Physiol. doi:10.1152/ajpregu.00102.2013
21. Sabino JPJ, da Silva CAA, de Melo RF, Fazan R Jr, Salgado HC (2013) The treatment with pyridostigmine improves the cardiocirculatory function in rats with chronic heart failure. Auton Neurosci Basic Clin 173: 58-64. doi:10.1016/j.autneu.2012.11.007
22. De La Fuente RN, Rodrigues B, Moraes-Silva IC, Souza LE, Sirvente R, et al. (2013) Cholinergic stimulation with pyridostigmine improves autonomic function in infarcted rats. Clin Exp Pharmacol Physiol 40: 610-616. doi:10.1111/1440-1681.12121
23. Soares PP da S, da Nóbrega ACL, Ushizima MR, Irigoyen MCC (2004) Cholinergic stimulation with pyridostigmine increases heart rate variability and baroreflex sensitivity in rats. Auton Neurosci Basic Clin 113: 24-31. doi:10.1016/j.autneu.2004.05.002
24. Nóbrega AC, dos Reis AF, Moraes RS, Bastos BG, Ferlin EL, et al. (2001) Enhancement of heart rate variability by cholinergic stimulation with pyridostigmine in healthy subjects. Clin Auton Res Off J Clin Auton Res Soc 11: 11-17. (Pubitemid 33027785)
25. Behling A, Moraes RS, Rohde LE, Ferlin EL, Nóbrega ACL, et al. (2003) Cholinergic stimulation with pyridostigmine reduces ventricular arrhythmia and enhances heart rate variability in heart failure. Am Heart J 146: 494-500. doi:10.1016/S0002-8703(03)00319-3 (Pubitemid 37083085)
26. Dewland TA, Androne AS, Lee FA, Lampert RJ, Katz SD (2007) Effect of acetylcholinesterase inhibition with pyridostigmine on cardiac parasympathetic function in sedentary adults and trained athletes. Am J Physiol Heart Circ Physiol 293: H86-92. doi:10.1152/ajpheart.01339.2006 (Pubitemid 47105062)
27. Zimerman LI, Liberman A, Castro RRT, Ribeiro JP, Nóbrega ACL (2010) Acute electrophysiologic consequences of pyridostigmine inhibition of cholinesterase in humans. Braz J Med Biol Res Rev Bras Pesqui Médicas E Biológicas Soc Bras Biofísica Al 43: 211-216.
28. Castro RRT, Porphirio G, Serra SM, Nóbrega ACL (2004) Cholinergic stimulation with pyridostigmine protects against exercise induced myocardial ischaemia. Heart Br Card Soc 90: 1119-1123. doi:10.1136/hrt.2003.028167 (Pubitemid 39279893)
29. Castro RRT, Serra SM, Porphirio G, Mendes FSNS, Oliveira LPJ, et al. (2006) Pyridostigmine reduces QTc interval during recovery from maximal exercise in ischemic heart disease. Int J Cardiol 107: 138-139. doi:10.1016/j.ijcard. 2005.01.035 (Pubitemid 41767539)
30. Serra SM, Costa RV, Teixeira De Castro RR, Xavier SS, Nóbrega ACLD (2009) Cholinergic stimulation improves autonomic and hemodynamic profile during dynamic exercise in patients with heart failure. J Card Fail 15: 124-129. doi:10.1016/j.cardfail.2008.10.018
31. Androne AS, Hryniewicz K, Goldsmith R, Arwady A, Katz SD (2003) Acetylcholinesterase inhibition with pyridostigmine improves heart rate recovery after maximal exercise in patients with chronic heart failure. Heart Br Card Soc 89: 854-858. (Pubitemid 36920804)
32. Pacher P, Nagayama T, Mukhopadhyay P, Bátkai S, Kass DA (2008) Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats. Nat Protoc 3: 1422-1434. doi:10.1038/nprot.2008.138
33. Takagawa J, Zhang Y, Wong ML, Sievers RE, Kapasi NK, et al. (2007) Myocardial infarct size measurement in the mouse chronic infarction model: comparison of area- and length-based approaches. J Appl Physiol Bethesda Md 1985 102: 2104-2111. doi:10.1152/japplphysiol.00033.2007 (Pubitemid 47080740)
34. Higuchi ML, Moreira LF, Silvestre JM, Gutierrez PS, Savalli C, et al. (1999) Myocardial fiber diameter as a good indicator of outcome in Batista's operation. J Card Surg 14: 401-407.
35. Patten RD, Aronovitz MJ, Deras-Mejia L, Pandian NG, Hanak GG, et al. (1998) Ventricular remodeling in a mouse model of myocardial infarction. Am J Physiol 274: H1812-1820.
36. Bridgman P, Aronovitz MA, Kakkar R, Oliverio MI, Coffman TM, et al. (2005) Gender-specific patterns of left ventricular and myocyte remodeling following myocardial infarction in mice deficient in the angiotensin II type 1a receptor. Am J Physiol Heart Circ Physiol 289: H586-592. doi:10.1152/ajpheart. 00474.2004 (Pubitemid 41129372)
37. Infanger DW, Cao X, Butler SD, Burmeister MA, Zhou Y, et al. (2010) Silencing nox4 in the paraventricular nucleus improves myocardial infarction-induced cardiac dysfunction by attenuating sympathoexcitation and periinfarct apoptosis. Circ Res 106: 1763-1774. doi:10.1161/CIRCRESAHA.109. 213025
38. Arenja N, Mueller C, Ehl NF, Brinkert M, Roost K, et al. (2013) Prevalence, extent, and independent predictors of silent myocardial infarction. Am J Med 126: 515-522. doi:10.1016/j.amjmed.2012.11.028
39. Porter TR, Eckberg DL, Fritsch JM, Rea RF, Beightol LA, et al. (1990) Autonomic pathophysiology in heart failure patients. Sympathetic-cholinergic interrelations. J Clin Invest 85: 1362-1371. doi:10.1172/JCI114580 (Pubitemid 20176427)
40. Eckberg DL, Drabinsky M, Braunwald E (1971) Defective cardiac parasympathetic control in patients with heart disease. N Engl J Med 285: 877-883. doi:10.1056/NEJM197110142851602
41. Dunlap ME, Bibevski S, Rosenberry TL, Ernsberger P (2003) Mechanisms of altered vagal control in heart failure: influence of muscarinic receptors and acetylcholinesterase activity. Am J Physiol Heart Circ Physiol 285: H1632-1640. doi:10.1152/ajpheart.01051.2002 (Pubitemid 37169519)
42. Bernatova I, Dubovicky M, Price WA, Grubbs RD, Lucot JB, et al. (2003) Effect of chronic pyridostigmine bromide treatment on cardiovascular and behavioral parameters in mice. Pharmacol Biochem Behav 74: 901-907. (Pubitemid 36351654)
43. Schwartz PJ, De Ferrari GM (2011) Sympathetic-parasympathetic interaction in health and disease: abnormalities and relevance in heart failure. Heart Fail Rev 16: 101-107. doi:10.1007/s10741-010-9179-1.
44. Manabe N, Foldes FF, Töröcsik A, Nagashima H, Goldiner PL, et al. (1991) Presynaptic interaction between vagal and sympathetic innervation in the heart: modulation of acetylcholine and noradrenaline release. J Auton Nerv Syst 32: 233-242.
45. Watanabe AM, Lindemann JP, Fleming JW (1984) Mechanisms of muscarinic modulation of protein phosphorylation in intact ventricles. Fed Proc 43: 2618-2623. (Pubitemid 14056001)
46. Azevedo ER, Parker JD (1999) Parasympathetic control of cardiac sympathetic activity: normal ventricular function versus congestive heart failure. Circulation 100: 274-279. (Pubitemid 29340134)
47. Manabe N, Foldes FF, Töröcsik A, Nagashima H, Goldiner PL, et al. (1991) Presynaptic interaction between vagal and sympathetic innervation in the heart: modulation of acetylcholine and noradrenaline release. J Auton Nerv Syst 32: 233-242.
48. Muscholl E (1980) Peripheral muscarinic control of norepinephrine release in the cardiovascular system. Am J Physiol 239: H713-720.
49. Watanabe AM, Lindemann JP, Fleming JW (1984) Mechanisms of muscarinic modulation of protein phosphorylation in intact ventricles. Fed Proc 43: 2618-2623. (Pubitemid 14056001)
50. Levy MN (1971) Sympathetic-parasympathetic interactions in the heart. Circ Res 29: 437-445.
51. Vanhoutte PM, Levy MN (1980) Prejunctional cholinergic modulation of adrenergic neurotransmission in the cardiovascular system. Am J Physiol 238: H275-281. (Pubitemid 10118478)
52. Levy MN, Zieske H (1969) Autonomic control of cardiac pacemaker activity and atrioventricular transmission. J Appl Physiol 27: 465-470.
53. Kumashiro H, Kusachi S, Moritani H, Ohnishi H, Nakahama M, et al. (1999) Establishment of a long-surviving murine model of myocardial infarction: qualitative and quantitative conventional microscopic findings during pathological evolution. Basic Res Cardiol 94: 78-84. (Pubitemid 29182381)
54. Sam F, Sawyer DB, Chang DL, Eberli FR, Ngoy S, et al. (2000) Progressive left ventricular remodeling and apoptosis late after myocardial infarction in mouse heart. Am J Physiol Heart Circ Physiol 279: H422-428. (Pubitemid 30616685)
55. Zhang Y, Popovic ZB, Bibevski S, Fakhry I, Sica DA, et al. (2009) Chronic vagus nerve stimulation improves autonomic control and attenuates systemic inflammation and heart failure progression in a canine high-rate pacing model. Circ Heart Fail 2: 692-699. doi:10.1161/CIRCHEARTFAILURE.109.873968
56. Handa T, Katare RG, Kakinuma Y, Arikawa M, Ando M, et al. (2009) Anti-Alzheimer's drug, donepezil, markedly improves long-term survival after chronic heart failure in mice. J Card Fail 15: 805-811. doi:10.1016/j.cardfail. 2009.05.008
57. Okazaki Y, Zheng C, Li M, Sugimachi M (2010) Effect of the cholinesterase inhibitor donepezil on cardiac remodeling and autonomic balance in rats with heart failure. J Physiol Sci JPS 60: 67-74. doi:10.1007/s12576-009-0071-5